Enediyne Chimeras for Targeted NAMPT Degradation: Enhancing Cytotoxicity via a Radical Clock
- 27 July 2026
- journal article
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 91 (31) , 10747-10752
Abstract
Based on a novel targeted protein degradation platform, Protein-Radical-Oxidation Targeting Enediyne Chimera (PROTEC), a series of chimeric enediyne compounds targeting the oncogenic protein nicotinamide phosphoribosyltransferase (NAMPT) were designed and synthesized. These compounds feature different linker lengths and cyclopropane modifications at the alkyne terminus. Computational studies showed that incorporating the cyclopropane group at the propargyl position facilitates the “radical clock” mechanism, achieving greater spatial separation and weaker orbital interactions between the two radical centers, thereby enhancing hydrogen abstraction ability. The PROTEC-4 compound exhibiting the strongest interaction with NAMPT, as demonstrated by docking studies, established significant cytotoxicity against human ovarian cancer A2780 cells with a half-inhibitory concentration (IC50) of 0.24 μM, indicating great potential for future antitumor drug development.Keywords
Funding Information
- National Natural Science Foundation of China (32470158)
- Chinese Academy of Sciences (XDB0490000)
- Graduate Program in Physics at UNIFAL-MG (23141902400)
This publication has 32 references indexed in Scilit:
- Advancements in Proteolysis Targeting Chimeras for Targeted Therapeutic Strategies in Alzheimer’s DiseaseMolecular Neurobiology, 2025
- Targeted protein degradation: current molecular targets, localization, and strategiesDrug Discovery Today, 2024
- Hydrophobic tagging-induced degradation of NAMPT in leukemia cellsChinese Chemical Letters, 2023
- Addressing the Enzyme-independent tumor-promoting function of NAMPT via PROTAC-mediated degradationCell Chemical Biology, 2022
- Targeted protein degradation: A promise for undruggable proteinsCell Chemical Biology, 2021
- Discovery of novel VEGFR-2 inhibitors embedding 6,7-dimethoxyquinazoline and diarylamide fragmentsBioorganic & Medicinal Chemistry Letters, 2021
- Total Synthesis of a Mycolic Acid from Mycobacterium tuberculosisAngewandte Chemie International Edition, 2020
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitorInvestigational New Drugs, 2007
- Measurement of serum ferritin by a 2-site immunoradiometric assayAnalytical Biochemistry, 1974